Dr. Lawrence M. Samkoff, MD

Dr. Samkoff practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Samkoff's NPI, 1407882541, was assigned on June 23, 2006. Dr. Samkoff graduated from New York Medical College in 1984. Dr. Samkoff holds New York license 167334.

Dr. Samkoff's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Samkoff's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Samkoff is also affiliated with Rochester General Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Samkoff to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samkoff practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Samkoff's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Samkoff is licensed in New York.

CMS data shows 98 Medicare services from Dr. Samkoff across 3 procedure codes in 2024, all of them office visits, for 117 Medicare patients. Medicare paid $6,585 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Samkoff in 2024. The largest group is under 65, with 51 patients. 65% of them have high cholesterol, and 60% have high blood pressure. 43% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samkoff's median patient age at 54, with 69% women.

In 2024, Dr. Samkoff wrote 1,028 Medicare Part D claims for 157 patients. 85% of them were for generic drugs. CMS names the drug for 818 of them, across 22 drugs with 11 or more claims each, at $948,867 in total drug cost. In 2023, CMS named 173 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Samkoff for performance year 2024, reported as part of a group. Dr. Samkoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samkoff as offering telehealth.

Dmand AI links 12 papers to Dr. Samkoff, published from 2016 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Autoantibodies, Hypertrophy and Meningitis. Dr. Samkoff has published most often in Neurology. Dr. Samkoff's most frequent co-authors are Maxime Junior Jean, MD, PhD, Andrea Christina Wasilewski, MD and Ryan P. Canissario, MD.

Dmand AI links Dr. Samkoff to 1 clinical trial. Conditions studied include Multiple Sclerosis, Chronic Progressive and Multiple Sclerosis.

CMS Open Payments shows 1 general payment to Dr. Samkoff from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $72. It also lists 1 research payment totaling $464 in 2019.

Dr. Samkoff graduated from New York Medical College in 1984.